UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 93

Sortiert nach

Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma

Journal of thoracic oncology, 2017-09, Vol.12 (9), p.1421-1433

2017

Volltextzugriff (PDF)

Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma

Journal of thoracic oncology, 2018-02, Vol.13 (2), p.258-272

2018

Volltextzugriff (PDF)

The Role of E-Cadherin and microRNA on FAK Inhibitor Response in Malignant Pleural Mesothelioma (MPM)

International journal of molecular sciences, 2021-10, Vol.22 (19), p.10225

2021

Volltextzugriff (PDF)

3-Dimensional mesothelioma spheroids provide closer to natural pathophysiological tumor microenvironment for drug response studies

Frontiers in oncology, 2022-08, Vol.12, p.973576-973576

2022

Volltextzugriff (PDF)

CDKN2A and MTAP Are Useful Biomarkers Detectable by Droplet Digital PCR in Malignant Pleural Mesothelioma: A Potential Alternative Method in Diagnosis Compared to Fluorescence In Situ Hybridisation

Frontiers in oncology, 2020-11, Vol.10, p.579327-579327

2020

Volltextzugriff (PDF)

Lidocaine for Neuropathic Cancer Pain (LiCPain): study protocol for a mixed-methods pilot study

BMJ open, 2023-02, Vol.13 (2), p.e066125-e066125

2023

Volltextzugriff (PDF)

Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study

The lancet oncology, 2017-10, Vol.18 (10), p.1386-1396

2017

Volltextzugriff (PDF)

Investigating the Use of Electronic Well-being Diaries Completed Within a Psychoeducation Program for University Students: Longitudinal Text Analysis Study

Journal of medical Internet research, 2021-04, Vol.23 (4), p.e25279-e25279

2021

Volltextzugriff (PDF)

High mesothelin expression by immunohistochemistry predicts improved survival in pleural mesothelioma

Histopathology, 2023-08, Vol.83 (2), p.202-210

2023

Volltextzugriff (PDF)

High BIN1 expression has a favorable prognosis in malignant pleural mesothelioma and is associated with tumor infiltrating lymphocytes

Lung cancer (Amsterdam, Netherlands), 2019-04, Vol.130, p.35-41

2019

Volltextzugriff (PDF)

GUIDE: A randomized non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (ANZUP 1903)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS5099-TPS5099

2023

Volltextzugriff (PDF)

The minimum standard of care for managing malignant pleural mesothelioma in developing nations within the Asia‐Pacific Region

Asia-Pacific journal of clinical oncology, 2022-06, Vol.18 (3), p.177-190

2022

Volltextzugriff (PDF)

Street Youth in Toronto, Canada: An Investigation of Demographic Predictors of HIV Status Among Street Youth Who Access Preventive Health and Social Services

Journal of HIV/AIDS & social services, 2009-12, Vol.8 (4), p.375-396

2009

Volltextzugriff (PDF)

The ticking time-bomb of asbestos: Its insidious role in the development of malignant mesothelioma

Critical reviews in oncology/hematology, 2012-11, Vol.84 (2), p.200-212

2012

Volltextzugriff (PDF)

Patterns of care and survival of older patients with malignant pleural mesothelioma

Journal of geriatric oncology, 2019-07, Vol.10 (4), p.573-576

2019

Volltextzugriff (PDF)

Real world efficacy and toxicity of consolidation durvalumab following chemoradiotherapy in older Australian patients with unresectable stage III non-small cell lung cancer

Journal of geriatric oncology, 2024-03, Vol.15 (2), p.101705-101705, Article 101705

2024

Volltextzugriff (PDF)

Evaluation of a mainstream model of genetic testing for men with prostate cancer

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.1521-1521

2020

Volltextzugriff (PDF)

Geographic and socioeconomic factors in patients with malignant pleural mesothelioma in New South Wales and their impact upon clinical outcomes

Respirology (Carlton, Vic.), 2017-07, Vol.22 (5), p.978-985

2017

Volltextzugriff (PDF)

IMMU-50. THE IMMUNE LANDSCAPE OF BLOOD DENDRITIC CELLS IN GLIOBLASTOMA MULTIFORME: IMPLICATIONS FOR DC VACCINATION COMBINED WITH CHECKPOINT INHIBITION

Neuro-oncology (Charlottesville, Va.), 2018-11, Vol.20 (suppl_6), p.vi132-vi132

2018

Volltextzugriff (PDF)

RTID-05. THE MULTI-ARM GLIOBLASTOMA AUSTRALASIA (MAGMA) TRIAL

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi193-vi194

2021

Volltextzugriff (PDF)

miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma

Oncotarget, 2015-09, Vol.6 (27), p.23480-23495

2015

Volltextzugriff (PDF)

The Current Understanding Of Asbestos-Induced Epigenetic Changes Associated With Lung Cancer

Lung cancer (Auckland), 2020-01, Vol.11, p.1-11

2020

Volltextzugriff (PDF)

P3.03-033 The Influence of Geographic and Socioeconomic Factors on Prognosis and Treatment Provision in Malignant Pleural Mesothelioma: Topic: Mesothelioma Clinical

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1364-S1365

2017

Volltextzugriff (PDF)

P3.03-033 The Influence of Geographic and Socioeconomic Factors on Prognosis and Treatment Provision in Malignant Pleural Mesothelioma

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1364-S1365

2017

Volltextzugriff (PDF)

Glasgow Prognostic Score As a Prognostic Factor in Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel-Based Chemotherapy

Clinical genitourinary cancer, 2013-12, Vol.11 (4), p.423-430

2013

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(82)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma

Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma

The Role of E-Cadherin and microRNA on FAK Inhibitor Response in Malignant Pleural Mesothelioma (MPM)

3-Dimensional mesothelioma spheroids provide closer to natural pathophysiological tumor microenvironment for drug response studies

CDKN2A and MTAP Are Useful Biomarkers Detectable by Droplet Digital PCR in Malignant Pleural Mesothelioma: A Potential Alternative Method in Diagnosis Compared to Fluorescence In Situ Hybridisation

Lidocaine for Neuropathic Cancer Pain (LiCPain): study protocol for a mixed-methods pilot study

Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study

Investigating the Use of Electronic Well-being Diaries Completed Within a Psychoeducation Program for University Students: Longitudinal Text Analysis Study

High mesothelin expression by immunohistochemistry predicts improved survival in pleural mesothelioma

High BIN1 expression has a favorable prognosis in malignant pleural mesothelioma and is associated with tumor infiltrating lymphocytes

GUIDE: A randomized non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (ANZUP 1903)

The minimum standard of care for managing malignant pleural mesothelioma in developing nations within the Asia‐Pacific Region

Street Youth in Toronto, Canada: An Investigation of Demographic Predictors of HIV Status Among Street Youth Who Access Preventive Health and Social Services

The ticking time-bomb of asbestos: Its insidious role in the development of malignant mesothelioma

Patterns of care and survival of older patients with malignant pleural mesothelioma

Real world efficacy and toxicity of consolidation durvalumab following chemoradiotherapy in older Australian patients with unresectable stage III non-small cell lung cancer

Evaluation of a mainstream model of genetic testing for men with prostate cancer

Geographic and socioeconomic factors in patients with malignant pleural mesothelioma in New South Wales and their impact upon clinical outcomes

IMMU-50. THE IMMUNE LANDSCAPE OF BLOOD DENDRITIC CELLS IN GLIOBLASTOMA MULTIFORME: IMPLICATIONS FOR DC VACCINATION COMBINED WITH CHECKPOINT INHIBITION

RTID-05. THE MULTI-ARM GLIOBLASTOMA AUSTRALASIA (MAGMA) TRIAL

miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma

The Current Understanding Of Asbestos-Induced Epigenetic Changes Associated With Lung Cancer

P3.03-033 The Influence of Geographic and Socioeconomic Factors on Prognosis and Treatment Provision in Malignant Pleural Mesothelioma: Topic: Mesothelioma Clinical

P3.03-033 The Influence of Geographic and Socioeconomic Factors on Prognosis and Treatment Provision in Malignant Pleural Mesothelioma

Glasgow Prognostic Score As a Prognostic Factor in Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel-Based Chemotherapy

Suchergebnisse filtern